PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsgraft vs host disease
MeSH D006086 - graft vs host disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007154:Immune system diseases
$
Success rate
D006086: 
Graft vs host disease
D000092122:Bronchiolitis obliterans syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyMethylprednisolone Methylprednisolone  1982-01-01   
Prednisone Prednisone  1982-01-01   
Abbott BiotherapeuticsMethylprednisolone A-methapred  1991-02-22   
Accord HealthcareMycophenolate mofetil Mycophenolate Mofetil  2009-05-04   
Tacrolimus Tacrolimus  2011-08-31   
Mycophenolic acid Mycophenolic  2017-08-23   
Alkem LaboratoriesMycophenolate mofetil Mycophenolate Mofetil  2011-11-04   
Tacrolimus Tacrolimus  2020-11-12   
Mycophenolic acid Mycophenolic  2021-09-23   
AllerganMethylprednisolone Methylprednisolone  1997-10-16   
Prednisone Prednisone  1982-01-01   
American TherapeuticsPrednisone Prednisone  1986-11-06   
Amneal PharmaceuticalsMethylprednisolone Methylprednisolone  2021-09-21   
Mycophenolate mofetil Mycophenolate Mofetil  2010-07-16   
Prednisone Prednisone  1987-10-05   
Amta LaboratoriesMycophenolic acid Mycophenolic  2021-02-10   
ApotexMycophenolate mofetil Mycophenolate Mofetil  2009-04-22   
Mycophenolic acid Mycophenolic  2012-08-21   
APP PharmaceuticalsMethylprednisolone Methylprednisolone  1984-06-08   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
81%
67/83
Phase 2
39%
47/119
Phase 3
47%
29/62
Approved: 9Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Accord Healthcare
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use